| # | Drug | Count |
|---|---|---|
| 0 | IBUPFROFEN | 19 |
| 1 | IBUPROFEN | 19 |
| 2 | IBUPROFEN 200 MG | 19 |
| 3 | IBUPROFEN 200MG | 19 |
| 4 | IBUPROFEN CAPSULE | 19 |
| 5 | IBUPROFEN CAPSULES 200 MG | 19 |
| 6 | IBUPROFEN ORAL | 19 |
| 7 | IBUPROFEN TABLET, FILM COATED | 19 |
| 8 | IBUPROFEN TABLET, FILM-COATED | 19 |
| 9 | IBUPROFEN TABLETS USP, 200MG | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 1 | BUTORPHANOL TARTRATE | 1 | 0.0030 |
| 2 | DIHYDROERGOTAMINE MESYLATE | 4 | 0.0030 |
| 3 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 4 | ZAVEGEPANT | 1 | 0.0011 |
| 5 | GOLIMUMAB | 14 | 0.0011 |
| 6 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 7 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 8 | BETAINE | 1 | 0.0010 |
| 9 | ADALIMUMAB-RYVK | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 2 | Corticosteroid [EPC] | 18 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 4 | Mood Stabilizer [EPC] | 12 |
| 5 | Acetylcholine Release Inhibitor [EPC] | 11 |
| 6 | Anti-epileptic Agent [EPC] | 11 |
| 7 | Neuromuscular Blocker [EPC] | 11 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 10 |
| 9 | Benzodiazepine [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Calcitonin Gene-related Peptide Antagonist [EPC] | 6 | 0.0006 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 4 | 0.0006 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 5 | 0.0002 |
| 6 | Barbiturate [EPC] | 2 | 0.0002 |
| 7 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 11 | 0.0001 |